Literature DB >> 26225634

Manganese-Enhanced MRI for Preclinical Evaluation of Retinal Degeneration Treatments.

Rebecca M Schur1, Li Sheng1, Bhubanananda Sahu2, Guanping Yu1, Songqi Gao3, Xin Yu1, Akiko Maeda4, Krzysztof Palczewski3, Zheng-Rong Lu1.   

Abstract

PURPOSE: Apply manganese-enhanced magnetic resonance imaging (MEMRI) to assess ion channel activity and structure of retinas from mice subject to light-induced retinal degeneration treated with prophylactic agents.
METHODS: Abca4(-/-)Rdh8(-/-) double knockout mice with and without prophylactic retinylamine (Ret-NH2) treatment were illuminated with strong light. Manganese-enhanced MRI was used to image the retina 2 hours after intravitreous injection of MnCl2 into one eye. Contrast-enhanced MRIs of the retina and vitreous humor in each experimental group were assessed and correlated with the treatment. Findings were compared with standard structural and functional assessments of the retina by optical coherence tomography (OCT), histology, and electroretinography (ERG).
RESULTS: Manganese-enhanced MRI contrast in the retina was high in nonilluminated and illuminated Ret-NH2-treated mice, whereas no enhancement was evident in the retina of the light-illuminated mice without Ret-NH2 treatment (P < 0.0005). A relatively high signal enhancement was also observed in the vitreous humor of mice treated with Ret-NH2. Strong MEMRI signal enhancement in the retinas of mice treated with retinylamine was correlated with their structural integrity and function evidenced by OCT, histology, and a strong ERG light response.
CONCLUSIONS: Manganese-enhanced MRI has the potential to assess the response of the retina to prophylactic treatment based on the measurement of ion channel activity. This approach could be used as a complementary tool in preclinical development of new prophylactic therapies for retinopathies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26225634      PMCID: PMC4525634          DOI: 10.1167/iovs.15-16522

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

1.  Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI.

Authors:  Bruce A Berkowitz; Robin Roberts; Dennis J Goebel; Hongmei Luan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

2.  Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.

Authors:  R Allikmets; N F Shroyer; N Singh; J M Seddon; R A Lewis; P S Bernstein; A Peiffer; N A Zabriskie; Y Li; A Hutchinson; M Dean; J R Lupski; M Leppert
Journal:  Science       Date:  1997-09-19       Impact factor: 47.728

3.  Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice.

Authors:  Akiko Maeda; Tadao Maeda; Marcin Golczak; Yoshikazu Imanishi; Patrick Leahy; Ryo Kubota; Krzysztof Palczewski
Journal:  Mol Pharmacol       Date:  2006-07-12       Impact factor: 4.436

4.  In vivo auditory brain mapping in mice with Mn-enhanced MRI.

Authors:  Xin Yu; Youssef Zaim Wadghiri; Dan H Sanes; Daniel H Turnbull
Journal:  Nat Neurosci       Date:  2005-07       Impact factor: 24.884

Review 5.  In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI).

Authors:  Robia G Pautler
Journal:  NMR Biomed       Date:  2004-12       Impact factor: 4.044

Review 6.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

7.  Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle.

Authors:  Marcin Golczak; Vladimir Kuksa; Tadao Maeda; Alexander R Moise; Krzysztof Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-25       Impact factor: 11.205

8.  Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function.

Authors:  Y J Lin; A P Koretsky
Journal:  Magn Reson Med       Date:  1997-09       Impact factor: 4.668

9.  Manganese fluxes and manganese-dependent neurotransmitter release in presynaptic nerve endings isolated from rat brain.

Authors:  P Drapeau; D A Nachshen
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

10.  Strontium, barium, and manganese metabolism in isolated presynaptic nerve terminals.

Authors:  H Rasgado-Flores; S Sanchez-Armass; M P Blaustein; D A Nachshen
Journal:  Am J Physiol       Date:  1987-06
View more
  10 in total

1.  Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.

Authors:  Da Sun; Rebecca M Schur; Avery E Sears; Song-Qi Gao; Amita Vaidya; Wenyu Sun; Akiko Maeda; Timothy Kern; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

2.  New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models.

Authors:  Rebecca M Schur; Songqi Gao; Guanping Yu; Yu Chen; Akiko Maeda; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  FASEB J       Date:  2018-01-24       Impact factor: 5.191

3.  Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease.

Authors:  Valérie Fontaine; Elodie Monteiro; Mylène Fournié; Elena Brazhnikova; Thinhinane Boumedine; Cécile Vidal; Christine Balducci; Louis Guibout; Mathilde Latil; Pierre J Dilda; Stanislas Veillet; José-Alain Sahel; René Lafont; Serge Camelo
Journal:  Aging (Albany NY)       Date:  2020-04-07       Impact factor: 5.682

Review 4.  Retinol Dehydrogenases Regulate Vitamin A Metabolism for Visual Function.

Authors:  Bhubanananda Sahu; Akiko Maeda
Journal:  Nutrients       Date:  2016-11-22       Impact factor: 5.717

5.  GARP2 accelerates retinal degeneration in rod cGMP-gated cation channel β-subunit knockout mice.

Authors:  Marci L DeRamus; Delores A Stacks; Youwen Zhang; Carrie E Huisingh; Gerald McGwin; Steven J Pittler
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

6.  Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber's Congenital Amaurosis.

Authors:  Da Sun; Bhubanananda Sahu; Songqi Gao; Rebecca M Schur; Amita M Vaidya; Akiko Maeda; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2017-02-28

Review 7.  Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration.

Authors:  Ryan A Cloyd; Shon A Koren; Jose F Abisambra
Journal:  Front Aging Neurosci       Date:  2018-12-13       Impact factor: 5.750

Review 8.  Applications of Manganese-Enhanced Magnetic Resonance Imaging in Ophthalmology and Visual Neuroscience.

Authors:  Wenyu Deng; Muneeb A Faiq; Crystal Liu; Vishnu Adi; Kevin C Chan
Journal:  Front Neural Circuits       Date:  2019-05-14       Impact factor: 3.492

Review 9.  Manganese-Enhanced Magnetic Resonance Imaging: Application in Central Nervous System Diseases.

Authors:  Jun Yang; Qinqing Li
Journal:  Front Neurol       Date:  2020-02-25       Impact factor: 4.003

10.  Effective gene therapy of Stargardt disease with PEG-ECO/pGRK1-ABCA4-S/MAR nanoparticles.

Authors:  Da Sun; Wenyu Sun; Song-Qi Gao; Jonathan Lehrer; Amirreza Naderi; Cheng Wei; Sangjoon Lee; Andrew L Schilb; Josef Scheidt; Ryan C Hall; Elias I Traboulsi; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-24       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.